. Experimental scheme. After 1 week acclimation, all mice were randomly divided into the following six groups (n = 8): normal (vehicle without DNCB treatment), control (DNCB treatment without AF or Dex treatment), AF 25 (Atofreellage 25 mg/mL with DNCB treatment), AF 50 (Atofreellage 50 mg/mL with DNCB treatment), AF 100 (Atofreellage 100 mg/mL with DNCB treatment), and Dex (dexamethasone 3 mg/kg with DNCB treatment). To induce AD-like skin inflammation, DNCB applied to mice daily for five weeks on the shaved dorsal skin, except for those of the normal group (0.4% DNCB for three weeks and then 0.2% DNCB for the following two weeks). Atofreellage (200 μL of 0, 25, 50, or 100 mg/mL, topically applied to the dorsal skin) or dexamethasone (Dex; 3 mg/kg, orally) was given to the corresponding groups daily for 2 weeks, at which point the mice were treated with 0.2% DNCB.
. Experimental scheme. After 1 week acclimation, all mice were randomly divided into the following six groups (n = 8): normal (vehicle without DNCB treatment), control (DNCB treatment without AF or Dex treatment), AF 25 (Atofreellage 25 mg/mL with DNCB treatment), AF 50 (Atofreellage 50 mg/mL with DNCB treatment), AF 100 (Atofreellage 100 mg/mL with DNCB treatment), and Dex (dexamethasone 3 mg/kg with DNCB treatment). To induce AD-like skin inflammation, DNCB applied to mice daily for five weeks on the shaved dorsal skin, except for those of the normal group (0.4% DNCB for three weeks and then 0.2% DNCB for the following two weeks). Atofreellage (200 μL of 0, 25, 50, or 100 mg/mL, topically applied to the dorsal skin) or dexamethasone (Dex; 3 mg/kg, orally) was given to the corresponding groups daily for 2 weeks, at which point the mice were treated with 0.2% DNCB. Total 1kg (each 100 g of fully dried 10 herbs) was mixed and boiled in 10 L of distilled water for 100 min at 100 °C, and then centrifuged for 30 min at 1500× g. The supernatant was lyophilized using a vacuumfreeze-drying system and obtained final extraction (yield 6.5%). 
